Webinar: Cyber Business Interruption and the Impact on the Pharmaceutical and Manufacturing Industry

June 11, 2018

Join Beecher Carlson on June 28, 2018, at 11:00 AM EST for the webinar, Cyber Business Interruption and the Impact on the Pharmaceutical and Manufacturing Industry: The Lessons Learned from Merck and How the Insurance Market. Click here to register.

While the cyber headlines continually report on the latest data breaches, the potentially biggest loss has nothing to do with privacy. Rather, the past year has featured an abundance of examples of the substantial costs involved with business interruption, extra expense, and supply chain interruption caused by cyber-attacks.

Perhaps none is more illustrative than the estimated nearly $1 billion Merck suffered due to NotPetya. It was an operational nightmare – disrupting not only manufacturing but research and sales as well. The insurance market, particularly the property market, is taking pause. What is the intent of their existing coverage for cyber related losses, and how will they manage coverage going forward?

In this webinar, we will discuss the following:

»Identify the interaction between product, property, cyber, and other insurance policies

»Pinpoint exposures including supply chain and other vulnerabilities

»Implement or revise a program to effectively cover cyber risks


Graeme Newman

Chief Innovation Officer | CFC Underwriting Ltd

Newman is the Chief Innovation Officer at CFC Underwriting and Head of Cyber. He spent the early part of his career consulting for Deloitte on a variety of cutting edge internet security projects, and today is at the forefront of the rapidly evolving cyber insurance market.

Thomas Bentz Jr.

Partner | Holland & Knight

Bentz practices insurance law with a focus on D&O, cyber, and other management liability insurance policies. He and his team provide insight and guidance on ways to improve policy language and helps insureds maximize their possible insurance recovery.

Jeffrey Mittleman

Partner | Holland & Knight

Mittleman is co-leader of the Healthcare & Life Sciences Industry Group and a member of the Compliance Services Team. He has published several articles and spoken at conferences regarding various health law issues, including compliance, fraud and abuse, pharmacy law, drug distribution, and managed care.

John Kerns

Executive Managing Director | Beecher Carlson

Kerns work closely with our equity partners in developing predictive loss models for Directors & Officers Liability. Prior to joining Beecher Carlson, he was at Marsh USA Inc. specializing in broking of Directors & Officers Liability, Professional Errors & Omissions Liability, the specialized coverage associated with Mergers & Acquisitions, as well as a wide array of Financial Risk Transfer products.

Reiner Braun

Senior Managing Director | Beecher Carlson

Braun serves as Beecher Carlson’s West Coast Property Practice Leader. He has more than 30 years of experience in the risk management and insurance industry with extensive work on the design and implementation of large, layered domestic and global property programs.

Chris Keegan

Senior Managing Director | Beecher Carlson

Keegan is Beecher Carlson’s Cyber and Technology Practice Leader in the Executive Liability Practice. Chris is closely involved with the development of new insurance products designed to transfer electronic risk and is often asked to speak on these topics at seminars and functions throughout the United States and Canada.